摘要
近年来在心脏病学领域提出了多种生物标志物,研究表明和肽素为一种新的内源性应激标志物,在急性心肌梗死早期释放,可作为早期诊断急性心肌梗死的血清学指标之一,也是评估急性心肌梗死患者临床结局的重要生物标志物,现就和肽素在急性心肌梗死中的研究进展做一综述。
In recent years,a variety of biomarkers have been proposed in the field of cardiology.Studies have shown that copeptin,as a new endogenous stress marker,which releases early in acute myocardial infarction(AMI),can be used as one of the serological indicators for diagnosing AMI at an early stage.Copeptin is also an important biomarker for assessing the clinical outcome of AMI.In this paper,we review the research progress of copeptin in AMI.
作者
崔小豪
杨志明
CUI Xiaohao;YANG Zhiming(Shanxi Medical University,Taiyuan 030000,Shanxi,China;Department of Cardiology,The Second Hospital of Shanxi Medical University,Taiyuan 030000,Shanxi,China)
出处
《心血管病学进展》
CAS
2019年第5期726-729,共4页
Advances in Cardiovascular Diseases
关键词
生物标志物
和肽素
诊断
预后
急性心肌梗死
Biomarker
Copeptin
Diagnosis
Prognosis
Acute myocardial infarction
